Pengyue Zhang

Computer SciencePharmacology, Toxicology and PharmaceuticsMathematicsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Network-based prediction of drug–target interactions using an arbitrary-order proximity embedded deep forest”.

Network-based prediction of drug–target interactions using an arbitrary-order proximity embedded deep forest

Bioinformatics(2020)10.1093/bioinformatics/btaa010

N/A

0DataRank · unranked

152 citations

Siyi Zhu, Yuan Hou, Pengyue Zhang, Lang Li, Jing Li +5 more

Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer’s Disease

medRxiv(2020)10.1101/2020.01.15.20017160

N/A

0DataRank · unranked

15 citations

Pengyue Zhang, Quan Wang, Yadi Zhou, Chien‐Wei Chiang, Rui Chen +8 more

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease

Nature Aging(2021)10.1038/s43587-021-00138-z

N/A

0DataRank · unranked

201 citations

Pengyue Zhang, Yadi Zhou, Chien‐Wei Chiang, Juan Tan, Yuan Hou +6 more

A multistate transition model for statin‐induced myopathy and statin discontinuation

CPT Pharmacometrics & Systems Pharmacology(2021)10.1002/psp4.12691

N/A

0DataRank · unranked

10 citations

Chien‐Wei Chiang, Lei Wang, Guy Brock, M. Wesley Milks, Weidan Cao +5 more

On Small-Sample Inference in Multiphase Stepped Wedge Cluster Randomized Trial (MSW-CRT) With Binary Outcomes

Research Square(2021)10.21203/rs.3.rs-993153/v1

N/A

0DataRank · unranked

0 citations

Abigail B. Shoben, Pengyue Zhang, Philip M. Westgate, Soledad Fernández, Jing Peng

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

Alzheimer s Research & Therapy(2022)10.1186/s13195-021-00951-z

N/A

0DataRank · unranked

121 citations

Pengyue Zhang, Quan Wang, Chien‐Wei Chiang, Yadi Zhou, Yuan Hou +11 more

An Early Adverse Drug Event Detection Approach with False Discovery Rate Control

medRxiv(2023)10.1101/2023.05.31.23290792

N/A

0DataRank · unranked

0 citations

Xueqiao Peng, Ruoqi Liu, Anna Sun, Yuedi Yang, Ping Zhang +3 more

Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101379

N/A

0DataRank · unranked

57 citations

Fei Wang, Jian Tang, Yadi Zhou, Zhimin Fu, Pengyue Zhang +8 more

Using multiple drug similarity networks to promote adverse drug event detection

Heliyon(2024)10.1016/j.heliyon.2024.e39728

N/A

0DataRank · unranked

2 citations

Ruoqi Liu, Yuedi Yang, Xueqiao Peng, Lang Li, Pengyue Zhang +2 more

TrajVis: a visual clinical decision support system to translate artificial intelligence trajectory models in the precision management of chronic kidney disease

arXiv (Cornell University)(2024)10.48550/arxiv.2401.08067

N/A

0DataRank · unranked

0 citations

Xiang Liu, Ziyang Tang, Pengyue Zhang, Nanxin Jin, Michael T. Eadon +4 more

Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation

Alzheimer s & Dementia Translational Research & Clinical Interventions(2025)10.1002/trc2.70193

N/A

0DataRank · unranked

0 citations

Ehud Karavani, Michael M. Danziger, Pengyue Zhang, Yuan Hou, Yadi Zhou +6 more